In addition, mir-432-3p has also been found to inhibit Keap1 expression in ESCC (esophageal squamous cell carcinoma), which in turn regulates the antioxidant activity of the Keap1-Nrf2 pathway (48–50). Here, NFE2L2 is linked to esophageal squamous cell carcinoma.